nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—SLC6A3—attention deficit hyperactivity disorder	0.445	0.572	CbGaD
Pethidine—SLC6A4—attention deficit hyperactivity disorder	0.333	0.428	CbGaD
Pethidine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00882	0.0908	CbGeAlD
Pethidine—ORM1—saliva—attention deficit hyperactivity disorder	0.00611	0.0629	CbGeAlD
Pethidine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00469	0.0483	CbGeAlD
Pethidine—GRIN2C—forebrain—attention deficit hyperactivity disorder	0.00355	0.0366	CbGeAlD
Pethidine—GRIN2D—forebrain—attention deficit hyperactivity disorder	0.0033	0.034	CbGeAlD
Pethidine—GRIN1—forebrain—attention deficit hyperactivity disorder	0.00294	0.0303	CbGeAlD
Pethidine—GRIN2B—forebrain—attention deficit hyperactivity disorder	0.00281	0.0289	CbGeAlD
Pethidine—GRIN2A—forebrain—attention deficit hyperactivity disorder	0.00245	0.0253	CbGeAlD
Pethidine—Milnacipran—SLC6A4—attention deficit hyperactivity disorder	0.00235	0.474	CrCbGaD
Pethidine—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0021	0.0216	CbGeAlD
Pethidine—GRIN1—midbrain—attention deficit hyperactivity disorder	0.00194	0.02	CbGeAlD
Pethidine—GRIN2C—nervous system—attention deficit hyperactivity disorder	0.00193	0.0199	CbGeAlD
Pethidine—GRIN2C—central nervous system—attention deficit hyperactivity disorder	0.00186	0.0191	CbGeAlD
Pethidine—GRIN2C—cerebellum—attention deficit hyperactivity disorder	0.00181	0.0187	CbGeAlD
Pethidine—GRIN2D—nervous system—attention deficit hyperactivity disorder	0.00179	0.0185	CbGeAlD
Pethidine—GRIN2D—central nervous system—attention deficit hyperactivity disorder	0.00173	0.0178	CbGeAlD
Pethidine—GRIN2D—cerebellum—attention deficit hyperactivity disorder	0.00169	0.0174	CbGeAlD
Pethidine—GRIN2A—midbrain—attention deficit hyperactivity disorder	0.00162	0.0167	CbGeAlD
Pethidine—GRIN1—nervous system—attention deficit hyperactivity disorder	0.0016	0.0164	CbGeAlD
Pethidine—GRIN1—central nervous system—attention deficit hyperactivity disorder	0.00154	0.0158	CbGeAlD
Pethidine—GRIN2B—nervous system—attention deficit hyperactivity disorder	0.00152	0.0157	CbGeAlD
Pethidine—GRIN1—cerebellum—attention deficit hyperactivity disorder	0.0015	0.0155	CbGeAlD
Pethidine—OPRM1—forebrain—attention deficit hyperactivity disorder	0.00149	0.0154	CbGeAlD
Pethidine—GRIN2C—brain—attention deficit hyperactivity disorder	0.00147	0.0152	CbGeAlD
Pethidine—GRIN2B—central nervous system—attention deficit hyperactivity disorder	0.00147	0.0151	CbGeAlD
Pethidine—GRIN2B—cerebellum—attention deficit hyperactivity disorder	0.00143	0.0148	CbGeAlD
Pethidine—GRIN2D—brain—attention deficit hyperactivity disorder	0.00137	0.0141	CbGeAlD
Pethidine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00135	0.0139	CbGeAlD
Pethidine—Levomilnacipran—SLC6A4—attention deficit hyperactivity disorder	0.00135	0.272	CrCbGaD
Pethidine—GRIN2A—nervous system—attention deficit hyperactivity disorder	0.00133	0.0137	CbGeAlD
Pethidine—GRIN2A—central nervous system—attention deficit hyperactivity disorder	0.00128	0.0132	CbGeAlD
Pethidine—Methylphenobarbital—CHRNA4—attention deficit hyperactivity disorder	0.00126	0.254	CrCbGaD
Pethidine—GRIN2A—cerebellum—attention deficit hyperactivity disorder	0.00125	0.0129	CbGeAlD
Pethidine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00124	0.0128	CbGeAlD
Pethidine—GRIN1—brain—attention deficit hyperactivity disorder	0.00122	0.0126	CbGeAlD
Pethidine—GRIN2B—brain—attention deficit hyperactivity disorder	0.00117	0.012	CbGeAlD
Pethidine—OPRK1—nervous system—attention deficit hyperactivity disorder	0.00114	0.0117	CbGeAlD
Pethidine—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.0011	0.0113	CbGeAlD
Pethidine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00109	0.0112	CbGeAlD
Pethidine—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.00107	0.011	CbGeAlD
Pethidine—GRIN2A—brain—attention deficit hyperactivity disorder	0.00102	0.0105	CbGeAlD
Pethidine—OPRM1—midbrain—attention deficit hyperactivity disorder	0.000985	0.0101	CbGeAlD
Pethidine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000894	0.00921	CbGeAlD
Pethidine—OPRK1—brain—attention deficit hyperactivity disorder	0.00087	0.00896	CbGeAlD
Pethidine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000819	0.00844	CbGeAlD
Pethidine—OPRM1—nervous system—attention deficit hyperactivity disorder	0.00081	0.00834	CbGeAlD
Pethidine—ORM1—nervous system—attention deficit hyperactivity disorder	0.000791	0.00814	CbGeAlD
Pethidine—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.00078	0.00803	CbGeAlD
Pethidine—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000761	0.00784	CbGeAlD
Pethidine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000735	0.00757	CbGeAlD
Pethidine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000708	0.00729	CbGeAlD
Pethidine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000692	0.00712	CbGeAlD
Pethidine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000681	0.00701	CbGeAlD
Pethidine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000674	0.00693	CbGeAlD
Pethidine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000649	0.00668	CbGeAlD
Pethidine—OPRM1—brain—attention deficit hyperactivity disorder	0.000619	0.00637	CbGeAlD
Pethidine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000598	0.00616	CbGeAlD
Pethidine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000593	0.00611	CbGeAlD
Pethidine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000571	0.00588	CbGeAlD
Pethidine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000562	0.00578	CbGeAlD
Pethidine—ALB—brain—attention deficit hyperactivity disorder	0.00053	0.00545	CbGeAlD
Pethidine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000515	0.0053	CbGeAlD
Pethidine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000453	0.00467	CbGeAlD
Pethidine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000437	0.0045	CbGeAlD
Pethidine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000421	0.00433	CbGeAlD
Pethidine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000334	0.00344	CbGeAlD
Pethidine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00033	0.0034	CbGeAlD
Pethidine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000325	0.00334	CbGeAlD
Pethidine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000318	0.00327	CbGeAlD
Pethidine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000313	0.00322	CbGeAlD
Pethidine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000306	0.00315	CbGeAlD
Pethidine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000248	0.00256	CbGeAlD
Pethidine—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000199	0.00167	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000196	0.00165	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000193	0.00162	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000192	0.00161	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000191	0.0016	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00019	0.00159	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000189	0.00159	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000189	0.00159	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000188	0.00158	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000186	0.00156	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000186	0.00156	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000185	0.00156	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000184	0.00155	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000183	0.00153	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000183	0.00153	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000181	0.00152	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000175	0.00147	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000172	0.00144	CbGpPWpGaD
Pethidine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000172	0.00144	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000172	0.00144	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00017	0.00143	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00017	0.00142	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000169	0.00142	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000168	0.00141	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.0014	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000165	0.00139	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000165	0.00139	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000163	0.00137	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000163	0.00137	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000162	0.00136	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000162	0.00136	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000161	0.00135	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000161	0.00135	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00016	0.00134	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00016	0.00134	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000159	0.00134	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000158	0.00133	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000158	0.00133	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000157	0.00132	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000157	0.00131	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.0013	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000155	0.0013	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000154	0.00129	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000153	0.00129	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000153	0.00128	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.000151	0.00127	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000151	0.00127	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00015	0.00126	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000148	0.00124	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000148	0.00124	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000145	0.00122	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000144	0.00121	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000143	0.0012	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000141	0.00119	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00014	0.00117	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00014	0.00117	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000138	0.00116	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000137	0.00115	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000135	0.00114	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000133	0.00112	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.00112	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000131	0.0011	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000131	0.0011	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000131	0.0011	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000131	0.0011	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00013	0.00109	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.00109	CbGpPWpGaD
Pethidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00013	0.00109	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00013	0.00109	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000127	0.00107	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000125	0.00105	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000122	0.00103	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000122	0.00103	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000121	0.00101	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000121	0.00101	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00012	0.00101	CbGpPWpGaD
Pethidine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000119	0.001	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000118	0.000991	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000114	0.00096	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000114	0.00096	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.000943	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000111	0.000932	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000111	0.000929	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000111	0.000929	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000109	0.000914	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000107	0.000896	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000106	0.000893	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000103	0.000868	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000103	0.000865	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.00085	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0001	0.000839	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0001	0.000839	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.89e-05	0.00083	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.69e-05	0.000813	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.67e-05	0.000812	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	9.54e-05	0.000801	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.32e-05	0.000782	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	9.26e-05	0.000777	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.21e-05	0.000773	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	9.19e-05	0.000772	CbGpPWpGaD
Pethidine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	9.19e-05	0.000771	CbGpPWpGaD
Pethidine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	9.12e-05	0.000766	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	9.11e-05	0.000764	CbGpPWpGaD
Pethidine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	9.06e-05	0.000761	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	9.02e-05	0.000757	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.99e-05	0.000755	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.71e-05	0.000731	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.71e-05	0.000731	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.57e-05	0.000719	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.56e-05	0.000718	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.45e-05	0.00071	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8.45e-05	0.000709	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.36e-05	0.000702	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	8.3e-05	0.000696	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.19e-05	0.000688	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	7.95e-05	0.000667	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.88e-05	0.000661	CbGpPWpGaD
Pethidine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	7.8e-05	0.000655	CbGpPWpGaD
Pethidine—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	7.8e-05	0.000655	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.4e-05	0.000621	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.36e-05	0.000618	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.24e-05	0.000608	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.94e-05	0.000583	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.89e-05	0.000579	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.85e-05	0.000575	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.8e-05	0.000571	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	6.78e-05	0.000569	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.72e-05	0.000564	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.61e-05	0.000555	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	6.54e-05	0.000549	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.53e-05	0.000548	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.47e-05	0.000543	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.39e-05	0.000536	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.34e-05	0.000532	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.3e-05	0.000529	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.25e-05	0.000525	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.01e-05	0.000505	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.87e-05	0.000493	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.84e-05	0.000491	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.82e-05	0.000489	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.75e-05	0.000483	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.73e-05	0.000481	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.72e-05	0.00048	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.68e-05	0.000477	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.65e-05	0.000474	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.62e-05	0.000471	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.52e-05	0.000463	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.47e-05	0.000459	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.46e-05	0.000458	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.29e-05	0.000444	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.27e-05	0.000442	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.2e-05	0.000436	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.13e-05	0.000431	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.08e-05	0.000426	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.96e-05	0.000417	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.94e-05	0.000415	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.92e-05	0.000413	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.84e-05	0.000406	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.84e-05	0.000406	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.78e-05	0.000401	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.78e-05	0.000401	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.75e-05	0.000398	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.61e-05	0.000387	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.47e-05	0.000375	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.45e-05	0.000374	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—EP300—attention deficit hyperactivity disorder	4.4e-05	0.000369	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.39e-05	0.000369	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.34e-05	0.000364	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—EP300—attention deficit hyperactivity disorder	4.29e-05	0.00036	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.18e-05	0.00035	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.15e-05	0.000348	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.12e-05	0.000346	CbGpPWpGaD
Pethidine—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	4.1e-05	0.000344	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.04e-05	0.000339	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.97e-05	0.000333	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.76e-05	0.000315	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.69e-05	0.00031	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.47e-05	0.000291	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.35e-05	0.000282	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.35e-05	0.000281	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.32e-05	0.000279	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.23e-05	0.000271	CbGpPWpGaD
Pethidine—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.16e-05	0.000265	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.12e-05	0.000262	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.12e-05	0.000262	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.07e-05	0.000258	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.03e-05	0.000254	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.93e-05	0.000246	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.84e-05	0.000238	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.83e-05	0.000238	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.82e-05	0.000237	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.73e-05	0.000229	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.64e-05	0.000222	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.61e-05	0.000219	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.59e-05	0.000218	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.59e-05	0.000218	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.59e-05	0.000218	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.56e-05	0.000215	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.55e-05	0.000214	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.39e-05	0.0002	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.37e-05	0.000199	CbGpPWpGaD
Pethidine—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	2.18e-05	0.000183	CbGpPWpGaD
Pethidine—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.18e-05	0.000183	CbGpPWpGaD
Pethidine—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	2.15e-05	0.00018	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.07e-05	0.000174	CbGpPWpGaD
Pethidine—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2e-05	0.000168	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.98e-05	0.000166	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000166	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.96e-05	0.000164	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.96e-05	0.000164	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.93e-05	0.000162	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.8e-05	0.000151	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.8e-05	0.000151	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.79e-05	0.00015	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.77e-05	0.000149	CbGpPWpGaD
Pethidine—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.75e-05	0.000146	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.71e-05	0.000143	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.67e-05	0.00014	CbGpPWpGaD
Pethidine—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.66e-05	0.000139	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.65e-05	0.000138	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.57e-05	0.000132	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.57e-05	0.000131	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.56e-05	0.000131	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.49e-05	0.000125	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.44e-05	0.000121	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	1.4e-05	0.000117	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.37e-05	0.000115	CbGpPWpGaD
Pethidine—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	1.32e-05	0.000111	CbGpPWpGaD
Pethidine—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.31e-05	0.00011	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.27e-05	0.000107	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.19e-05	9.97e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.18e-05	9.9e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.18e-05	9.89e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.18e-05	9.89e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.16e-05	9.73e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.14e-05	9.6e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.09e-05	9.17e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.08e-05	9.1e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.08e-05	9.05e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.05e-05	8.8e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.42e-06	7.91e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.97e-06	7.53e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.86e-06	7.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.14e-06	5.99e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.09e-06	5.95e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	6.74e-06	5.66e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	5.67e-06	4.76e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.09e-06	4.27e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.68e-06	3.93e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.06e-06	2.57e-05	CbGpPWpGaD
